Incidence of Liver Injury After Beginning Antiretroviral Therapy with Efavirenz or Nevirapine

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations Aquitaine Cohort, France, 1996-19981999 · 148 citations
2. 2Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients2003 · 200 citations
3. 3Hepatotoxicity Associated With Antiretroviral Therapy in Adults Infected With Human Immunodeficiency Virus and the Role of Hepatitis C or B Virus Infection2000 · 960 citations
4. 4Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids2000 · 81 citations
5. 5Risk Factors for Severe Hepatic Injury After Introduction of Highly Active Antiretroviral Therapy2001 · 245 citations